IL6 and hepatocellular carcinoma: In HCC, CAF-derived IL-6 promotes HCC-cell EMT, which in turn activates the IL-6/JAK/STAT3 pathway to induce expression of TG2 for acquisition of EMT phenotypes [20,22,23].